Download fulltext HTML
Meybodi, N. F., Eftekhar, M., & Gandom, B. (2024). Intrauterine autologous platelet-rich plasma treatment in women with at least two implantation failures: A retrospective cohort study. International Journal of Reproductive BioMedicine (IJRM), 22(1), 9–16. https://doi.org/10.18502/ijrm.v22i1.15236

https://doi.org/10.18502/ijrm.v22i1.15236

statistics

  • 159 Abstract Views
  • 111 PDF Views
  • 0 HTML Views

authors

  • Neda Fattahi Meybodi

    Neda Fattahi Meybodi

    Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
  • Maryam Eftekhar

    Maryam Eftekhar

    Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
  • Behnaz Gandom

    Behnaz Gandom

    Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Published Date

  • Feb 18, 2024

Intrauterine autologous platelet-rich plasma treatment in women with at least two implantation failures: A retrospective cohort study

International Journal of Reproductive BioMedicine (IJRM) / International Journal of Reproductive BioMedicine (IJRM): Volume 22, Issue No. 1 / Pages 9–16

Abstract

Background: Finding the most effective way to improve implantation rate in women who are receiving assisted reproductive technology treatment is still a challenge.


Objective: This study aimed to assess the pregnancy outcomes of intrauterine platelet-rich plasma (PRP) therapy in women with a history of at least 2 implantation failures.


Materials and Methods: In this retrospective cohort study, data of 852 women who were candidates for frozen-thawed embryo transfer was extracted from their medical records from April 2017-September 2021 at Yazd Reproductive Sciences Institute, Yazd, Iran. Of these, 432 received intrauterine PRP treatment 48 hr before transfer (PRP group), and the results of the pregnancy outcomes compared with 420 of the control group who did not receive the treatment before transfer.


Results: Pregnancy outcomes, including chemical, clinical, ongoing pregnancy, and live birth rate were statistically significant in the PRP group (p < 0.001). However, when categorized according to the implantation history, this significant improvement in all 4 was only seen in women with at least 2 prior implantation failures. In women with a history of only one implantation failure, PRP therapy significantly improved the ongoing pregnancy and live birth rate (19.5%, p = 0.04). Also, in women who received donor eggs and had repeated implantation failure, PRP improved pregnancy outcomes clinically but not statistically (p = 0.15).


Conclusion: PRP seems to be effective in improving the pregnancy rate in women with a history of 2 or more implantation failures and also shows an increase in the live birth rate in women with only one implantation failure.


Key words: Platelet-rich plasma, Embryo implantation, Assisted reproductive technology, Ovum donor, Live birth rate.

References
[1] Nazari L, Salehpour S, Hoseini S, Zadehmodarres Sh, Ajori L. Effects of autologous platelet-rich plasma on implantation and pregnancy in repeated implantation failure: A pilot study. Int J Reprod BioMed 2016; 14: 625– 628.

[2] Kasius A, Smit JG, Torrance HL, Eijkemans MJ, Mol BW, Opmeer BC, et al. Endometrial thickness and pregnancy rates after IVF: A systematic review and meta-analysis. Hum Reprod Update 2014; 20: 530–541.

[3] Aghajanova L, Houshdaran S, Balayan S, Irwin J, Huddleston H, Giudice L. Platelets for endometrial regeneration: A novel approach. Fertil Steril 2016; 106: e82.

[4] Arefi S, Fazeli E, Esfahani M, Borhani N, Yamini N, Hosseini A, et al. Granulocyte-colony stimulating factor may improve pregnancy outcome in patients with history of unexplained recurrent implantation failure: An RCT. Int J Reprod BioMed 2018; 16: 299–304.

[5] Barad DH, Yu Y, Kushnir VA, Shohat-Tal A, Lazzaroni E, Lee H-J, et al. A randomized clinical trial of endometrial perfusion with granulocyte colony-stimulating factor in in vitro fertilization cycles: Impact on endometrial thickness and clinical pregnancy rates. Fertil Steril 2014; 101: 710– 715.

[6] Bos-Mikich A, Ferreira MO, de Oliveira R, Frantz N. Platelet-rich plasma or blood-derived products to improve endometrial receptivity? J Assist Reprod Genet 2019; 36: 613–620.

[7] Hviid MM, Macklon N. Immune modulation treatmentswhere is the evidence? Fertil Steril 2017; 107: 1284–1293.

[8] Jain S, Mahey R, Malhotra N, Kalaivani M, Sangeeta P, Bhatt A, et al. Effect of intrauterine perfusion of granulocyte colony-stimulating factor on endometrial parameters and in vitro fertilization outcome in women undergoing in vitro fertilization/intracytoplasmic sperm injection cycles: A randomized controlled trial. J Hum Reprod Sci 2018; 11: 254–260.

[9] Tandulwadkar SR, Naralkar MV, Surana AD, Selvakarthick M, Kharat AH. Autologous intrauterine platelet-rich plasma instillation for suboptimal endometrium in frozen embryo transfer cycles: A pilot study. J Hum Reprod Sci 2017; 10: 208–212.

[10] Davari-Tanha F, Tehraninejad ES, Ghazi M, Shahraki Z. The role of G-CSF in recurrent implantation failure: A randomized double blind placebo control trial. Int J Reprod BioMed 2016; 14: 737–742.

[11] Huang C, Ye X, Ye L, Lu L, Liu F. Platelet-rich plasma intrauterine infusion as assisted reproduction technology (ART) to combat repeated implantation failure (RIF): A systematic review and meta-analysis. Iran J Public Health 2023; 52: 1542–1554.

[12] Welte K. G-CSF: Filgrastim, lenograstim and biosimilars. Expert Opin Biol Ther 2014; 14: 983–993.

[13] Zadehmodarres Sh, Salehpour S, Saharkhiz N, Nazari L. Treatment of thin endometrium with autologous platelet-rich plasma: A pilot study. JBRA Assist Reprod 2017; 21: 54–56.

[14] Eftekhar M, Neghab N, Khani P. Effectiveness of autologous platelet-rich plasma therapy in women with repeated implantation failure: An RCT. Int J Fertil Steril 2023; in Press.

[15] Eftekhar M, Neghab N, Naghshineh E, Khani P. Can autologous platelet rich plasma expand endometrial thickness and improve pregnancy rate during frozen-thawed embryo transfer cycle? A randomized clinical trial. Taiwan J Obstet Gynecol 2018; 57: 810–813.

[16] Tehraninejad ES, Kashani NG, Hosseini A, Tarafdari A. Autologous platelet-rich plasma infusion does not improve pregnancy outcomes in frozen embryo transfer cycles in women with history of repeated implantation failure without thin endometrium. J Obstet Gynaecol Res 2021; 47: 147–151.

[17] Ban Y, Yang X, Xing Y, Que W, Yu Z, Gui W, et al. Intrauterine infusion of leukocyte-poor platelet-rich plasma is an effective therapeutic protocol for patients with recurrent implantation failure: A retrospective cohort study. J Clin Med 2023; 12: 2823.

[18] Xu Y, Hao C, Fang J, Liu X, Xve P, Miao R. Intrauterine perfusion of autologous platelet-rich plasma before frozen-thawed embryo transfer improves the clinical pregnancy rate of women with recurrent implantation failure. Front Med 2022; 9: 64–67.

[19] Kong X, Tang G, Liu Y, Zheng Z, Li Y, Yan F. Efficacy of intrauterine infusion therapy before embryo transfer in recurrent implantation failure: A systematic review and network meta-analysis. J Reprod Immunol 2023; 156: 103819.

[20] Deng H, Wang S, Li Z, Xiao L, Ma L. Effect of intrauterine infusion of platelet-rich plasma for women with recurrent implantation failure: A systematic review and meta-analysis. J Obstet Gynaecol 2023; 43: 2144177.

[21] Kaur H, Meenu M, Pandey S, Chauhan A, Mangla M. Efficacy and safety of PRP in patients with recurrent implantation failure undergoing ART-A systematic review & meta-analysis. Authorea Preprints; 2023.

[22] Abd Elsalam Elgendy HE, Mohamed SA. Efficacy of intra-uterine infusion of PRP for pregnancy related outcomes in women with recurrent implantation failure; systematic review and meta-analysis of published trials. Egypt J Fertil Steril 2023; 27: 18–26.